Innovation is creating new ways to support oncologists
How ESMO is transforming the challenges from the COVID-19 pandemic into opportunities to re-shape the future of the oncology community
Artificial intelligence: a game-changer for the future of cancer care
Faced with an explosion in the complexity of genomic, imaging and clinical data, AI is rapidly becoming an indispensable tool for oncologists.
Real-world research does not need to replace randomised clinical trials to be recognised as valuable for treatment evaluation
According to Prof. Urania Dafni, high quality real-world evidence can provide broader information and more generalisable conclusions to verify the clinical applicability of evidence from RCTs
Prevention, the key to make cancer care sustainable
Medical oncologists have traditionally played a marginal role in helping drive the adoption of preventive lifestyles, “but now it is time to strengthen our commitment” says ESMO President
Are we ready to accept uncertainty in the name of cancer care sustainability?
The sustainability of health systems is critical for achieving a durable impact on population health.